Novocure announces 13 Tumor Treating Fields presentations at ASTRO
Novocure announced 13 presentations on Tumor Treating Fields at the American Society for Radiation Oncology, or ASTRO. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die. The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at this conference. Highlights include an analysis of the Radiation Therapy Oncology Group Recursive Partitioning Analysis scores in Novocure's EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma and the first presentation of an analysis of the correlation of dose density and survival outcomes in EF-14. An RPA score is a prognostic tool used to estimate a patient's prognosis.